Bone graft material specialist plans major facility development in UK
Following the successful completion of a US$45m fund raising initiative ApaTech, a leading bone graft technology specialist, is planning a major new facility development.
ApaTech has signed leases with ING Real Estate Investment Management acting on behalf of the Skandia Property Fund for a 11.5 year lease on two buildings at Centennial Park, Elstree, for a total of 32,000 sq ft of office, manufacturing and development activities. Adjacent to the company’s current location the new buildings provide a four-fold increase in manufacturing capacity, equivalent to sales of US$100-125m (E69m-79m) and office accommodation for an additional 45 UK-based staff.
Planning permission has been received for the $13m (€8.2) development and preparatory work to fit out the new facility has been initiated. Office occupancy is planned for January 2009, with manufacturing for sale intended from August 2009.
The company’s newest product, Actifuse, is being used in Europe, the US and Australasia for spinal fusions, bone tumor void filling, fractures and including use in the spine. The manufacturing facility is based in Elstree (Northwest London) England, with the US operations located in Foxborough, MA, in the greater Boston area.